Hour24 News
Sophisticated and simple
-
Insmed to Present at the 44th Annual JP Morgan Healthcare Conference Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company, announced its plan to present…
-
Overview: Mabwell’s Adalimumab Biosimilar Approved in Indonesia In a significant milestone for global biopharmaceutical access, Mabwell announced that its Adalimumab Injection 9MW0113—marketed as JUNMAIKANG in…
-
Groundbreaking Phase III topline results for Sparsentan in Japanese IgA nephropathy patients Renalys Pharma has announced positive topline results from a Phase III study evaluating…
-
Breakthrough in Obesity Treatment: GLORY-2 Report Highlights Mazdutide 9 mg Innovent Biologics and collaborating partners announced compelling results from the GLORY-2 phase 3 trial evaluating…
